July 8, 2020 11:02 AM EDT
News Briefing

Zai Lab inks Chi­na deal with Turn­ing Point with $25M up­front; Xen­cor, Atre­ca team up on bis­pecifics

Amber Tong

John Carroll

Editor & Founder

→ Zai Lab is pay­ing out a $25 mil­lion up­front for the rights to sell Turn­ing Point Ther­a­peu­tics’ lead drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CDER Di­rec­tor Pa­trizia Cavaz­zoni to step down ahead of Trump pres­i­den­cy

In­tel­lia to cut work­force by 27%, plans com­mer­cial­iza­tion of first CRISPR ther­a­py in 2027

Ex­clu­sive: Mod­er­na's for­mer top sci­en­tist has a new start­up us­ing AI to im­prove mR­NA ther­a­pies

Lil­ly ven­tures in­to pul­monary fi­bro­sis with start­up Me­di­ar

John Maraganore turns to ex-Al­ny­lam col­league to lead his lat­est RNAi bet; Amy­lyx names com­mer­cial chief

Four biotechs emerge with $800M and in-li­censed as­sets on Fri­day

A service from the Financial Times